血清アルブミンは,血症におけるアルブミンベースの比率と比較して,比較可能なまたは優れた予後値を示しています
Gianni Turcato1,2, Arian Zaboli3, Alessandro Cipriano4
1Department of Internal Medicine, Intermediate Care Unit, Hospital Alto Vicentino (AULSS-7), Santorso, Italy.
Current medical research and opinion
|September 5, 2025
まとめ
血清アルブミンはセプシス患者の30日間の死亡率を効果的に予測し,アルブミンの比率を上回ります. このバイオマーカーは,臨床実務における早期のリスク分層化に価値があります.
科学分野:
- クリティカル ケア 医療
- 臨床生化学
- 予測バイオマーカー
背景:
- 血清アルブミンは 認知されたセプシスのバイオマーカーです
- アルブミンベースの比率は,予後精度を改善するために提案されています.
- セプシスにおけるアルブミン対比の予後値については,まだ議論が続いている.
研究 の 目的:
- セプシスの30日間の死亡率における血清アルブミンとアルブミンベースの比率の予後性能を比較する.
- これらのマーカーの臨床的有用性を評価する.
- 血清アルブミンと確立された重症度スコアの相関性を評価する.
主な方法:
- 413人の成人セプシス患者を対象とした前向きな観察研究.
- 入院時の臨床データ,血清アルブミン,および6つのアルブミンベースの比率の収集
- ROC曲線,ブリアスコア,および決定曲線分析 (DCA) を使用した30日間の死亡率の評価.
主要な成果:
- 血清アルブミンは,試験されたすべての比率と比較して,30日間の死亡率の最も高い予測値を示した.
- DCAは,早期のリスク分層における血清アルブミンの優れた臨床的利益を確認した.
- 血清アルブミンはSOFAとAPACHE IIスコアと最も強い逆相関を示した.
結論:
- 血清アルブミンは30日間の死亡率の強固で独立した予測因子です.
- 血清アルブミンは,統計的および臨床的有用性においてアルブミンベースの比率を上回ります.
- 血清アルブミンの使用を推奨し,早期にセプシスのリスクを分別する.
関連する概念動画
01:24Serum Studies: Renal Function Tests
42
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
42
01:26Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:24Nephrotic Syndrome I : Introduction
25
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
25
01:29Drug Distribution: Plasma Protein Binding
6.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.6K
01:30Pneumonia III: Complications and Assessment
432
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
432